EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma

Josephine Q N Nguyen, Wojtek Drabarek, Aïsha M C H J Leeflang, Tom Brands, Thierry P P van den Bosch, Robert M Verdijk, Harmen J G van de Werken, Job van Riet, Dion Paridaens, Annelies de Klein, Erwin Brosens, Emine Kiliç and 1 more

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.12.11 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Josephine Q N Nguyen and 12 co-authors. Institution: Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands. Major MEDLINE topics: RNA Splicing Factors, Uveal Neoplasms, Melanoma, Spliceosomes. Cited 7 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

Unfortunately, treatment of patients with uveal melanoma (UM) with metastatic disease is limited. Twenty percent of patients with UM harbor a mutation in the splicing factor gene SF3B1, suggesting that aberrant spliceosome function plays a vital role in tumorigenesis. Splicing inhibitors exploit the preferential sensitivity of spliceosome-compromised leukemic cells to these compounds.

Methods

We studied the effect of the splicing inhibitor E7107 using two UM cell lines and ex vivo cultured SF3B1- and BAP1-mutated primary UM tumor slices. These UM cell lines and ex vivo tumor slices were exposed for 24 hours to different concentrations of E7107. Tumor slices were stained with hematoxylin and eosin (H&E) and incubated with BAP1, MelanA, MIB-1, and caspase-3 antisera.

Results

The E7107-exposed UM cell lines exhibited decreased cell viability and increased apoptosis, with the greatest effect on SF3B1-mutated UM cells. A similar effect on UM tumor slices was observed upon exposure to E7107. Additionally, RNA was isolated for differential isoform expression analysis. No significant difference in isoform usage was found genome-wide. However, specific genes were differentially expressed after E7107 treatment in the SF3B1-mutated samples. Moreover, E7107 had the greatest effect on intron retention.

Conclusions

This study indicates/suggests that mutated SF3B1 UM cells are more sensitive to the splicing inhibitor E7107 than wild-type SF3B1 UM cells.

Subjects

MeSH terms (MEDLINE)

RNA Splicing FactorsUveal NeoplasmsMelanomaSpliceosomesPhosphoproteinsApoptosisMutationHumansCell SurvivalCell Line, TumorUbiquitin ThiolesteraseTumor Cells, CulturedRibonucleoprotein, U2 Small NuclearRNA SplicingGene Expression Regulation, NeoplasticEpoxy CompoundsMacrolidesTumor Suppressor ProteinsUveal Melanoma

Substances

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsE 7107Ubiquitin ThiolesteraseRibonucleoprotein, U2 Small NuclearBAP1 protein, humanEpoxy CompoundsMacrolidesTumor Suppressor Proteins

Authors and institutions

  • Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.
  • Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.
  • The Rotterdam Eye Hospital, BH Rotterdam, The Netherlands.
  • Department of Pathology, Section Ophthalmic Pathology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.
  • Department of Pathology, Leiden University Medical Center, ZA Leiden, The Netherlands.
  • Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands.

Cite

APA

Nguyen, J. Q. N., Drabarek, W., Leeflang, A. M. C. H. J., Brands, T., van den Bosch, T. P. P., Verdijk, R. M., van de Werken, H. J. G., van Riet, J., Paridaens, D., de Klein, A., Brosens, E., Kiliç, E., & Rotterdam Ocular Melanoma Study Group (2024). The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.12.11

Vancouver

Nguyen JQN, Drabarek W, Leeflang AMCHJ, Brands T, van den Bosch TPP, Verdijk RM, et al. The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.12.11

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Josephine Q N and Drabarek, Wojtek and Leeflang, Aïsha M C H J and Brands, Tom and van den Bosch, Thierry P P and Verdijk, Robert M and van de Werken, Harmen J G and van Riet, Job and Paridaens, Dion and de Klein, Annelies and Brosens, Erwin and Kiliç, Emine and Rotterdam Ocular Melanoma Study Group, Rotterdam Ocular Melanoma Study Group},
  title = {The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.12.11}
}
Start for free →